Deep Track Capital, LP Passage Bio, Inc. Transaction History

Deep Track Capital, LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$1.22 - $2.48 $1.07 Million - $2.18 Million	-880,938 Reduced 37.97%	1,439,062 $1.8 Million
Q2 2022 Aug 12, 2022	SELL	$1.63 - $3.46 $1.72 Million - $3.65 Million	-1,055,000 Reduced 31.26%	2,320,000 $5.48 Million
Q1 2022 May 16, 2022	BUY	$2.66 - $6.49 $420,287 - $1.03 Million	158,003 Added 4.91%	3,375,000 $10.5 Million
Q4 2021 Feb 14, 2022	BUY	$6.24 - $10.2 $20.1 Million - $32.8 Million	3,216,997 New	3,216,997 $20.4 Million

38.7M

7.7K

Ticker PASG
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,463,200
Market Cap $32.1M
Description
Passage Bio, Inc., a genetic medicines company, develops transformative therapies for central nervous system diseases. It develops PBGM01, which utilizes a proprietary, AAVhu68 capsid to deliver to the brain and peripheral tissues a functional GLB1 gene encoding lysosomal acid beta-galactosidase for infantile GM1; PBFT02, which utilizes an AAV1 ...

Get notified when there are updates to the investment portfolio of Deep Track Capital, LP, based on Form 13F filings with the SEC.

Stay updated on Deep Track Capital, LP with notifications on news.